IB-STIM AURICULAR STIMULATOR

Serial Number 86937225
Registration 5978411
700

Registration Progress

Application Filed
Mar 11, 2016
Under Examination
Dec 13, 2016
Approved for Publication
Oct 18, 2016
Published for Opposition
Oct 18, 2016
Registered
Feb 4, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-04)
Due: Feb 04, 2026 186 days

Trademark Image

IB-STIM AURICULAR STIMULATOR

Basic Information

Serial Number
86937225
Registration Number
5978411
Filing Date
March 11, 2016
Registration Date
February 4, 2020
Published for Opposition
October 18, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 4, 2020
Registration
Registered
Classes
010

Rights Holder

NEURAXIS, INC.

03
Address
829 SOUTH ADAMS STREET
VERSAILLES, IN 47042

Ownership History

Innovative Health Solutions, Inc.

Original Applicant
03
Versailles, IN

Innovative Health Solutions, Inc.

Owner at Publication
03
Versailles, IN

Innovative Health Solutions, Inc.

Original Registrant
03
Versailles, IN

NEURAXIS, INC.

New Owner After Registration #1
03
VERSAILLES, IN

NEURAXIS, INC.

New Owner After Registration #2
03
VERSAILLES, IN

Legal Representation

Attorney
Brian J. McGinnis

USPTO Deadlines

Next Deadline
186 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-04)
Due Date
February 04, 2026
Grace Period Ends
August 04, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Jun 22, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 22, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 18, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Feb 4, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
May 19, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 27, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 27, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 27, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 27, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 27, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 4, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 28, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 27, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 11, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 9, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 9, 2019 IUAF S USE AMENDMENT FILED Loading...
Jun 12, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 11, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 11, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 7, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 7, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 12, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 10, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 10, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 10, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 10, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 1, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 30, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 30, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
May 30, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 13, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 11, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 11, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 11, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 8, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 6, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 6, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 6, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 13, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 18, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 18, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 28, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 6, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 23, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 23, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 23, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 1, 2016 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 1, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 1, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 25, 2016 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 010
Medical apparatus, namely, electrical nerve stimulators; Medical device, namely, a non-implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral nerves; Medical apparatus consisting of percutaneously implantable arrays for transmitting current into auricular and peri-auricular tissue; Medical device for peripheral nerve and nerve field stimulation; Medical device consisting of a non-implantable modulating frequency generator and percutaneously implantable needle arrays for transmitting current into auricular and peri-auricular tissue for use in pain management and FGID (functional gastrointestinal disorders), namely, patient stimulator for auricular and peri-auricular peripheral nerve field neuromodulation therapy; Medical apparatus, for peripheral nerve field stimulation in cranial and peripheral nerves and occipital nerve branches, for pain control, FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea, functional nausea, abdominal migraine, Crohn's Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes in FGID co-morbidities, sleep disturbances, psychological disorders, including mood and anxiety, satiety and changes in autonomic nervous system and other types of sympathetically mediated pain
First Use Anywhere: Sep 19, 2019
First Use in Commerce: Sep 19, 2019

Classification

International Classes
010

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"AURICULAR STIMULATOR"